Who Are We?
Founded in 1996, Toronto Memory Program is a multidisciplinary, community based, medical facility specializing in the diagnosis and treatment of Alzheimer’s disease and related disorders. We have one of the largest clinical trial programs for Alzheimer’s disease in the country. Our program serves the interests of patients and stakeholders locally, nationally and internationally. Our medical director, Dr. Sharon Cohen, is a Canadian-trained neurologist specializing in behaviour and cognition and an internationally recognized expert in this field.
Every individual treated in our clinic receives the best medical care available. This care is delivered by a knowledgeable and compassionate team in a relaxed and supportive setting. Treatment focuses on the well-being of both our patients and their families. We optimize the use of currently available pharmacological and non-pharmacological interventions and support patients and families through each stage of the disease.
Toronto Memory Program has taken part in over 80 international dementia research trials ranging from Phase I to Phase III. Clinical research allows for careful evaluation of new treatments designed to improve symptoms and/or alter the course of Alzheimer’s disease. We provide every eligible patient with opportunities to participate in research thereby allowing them to contribute to scientific knowledge and advances in the field. Patients regularly benefit from participation in research.
Toronto Memory Program believes in the importance of education for patients, their family, health care providers, allied health providers, government, and the public. We actively participate in a wide variety of teaching activities including training for medical students and pharmaceutical representatives. We believe that education is an important way to improve medical care and quality of life for those dealing with Alzheimer’s disease.